The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway
Open accessAbstract
// Shi-Peng Li 1, * , Hai-Xu Xu 3, * , Yao Yu 1, * , Jin-Dan He 1, * , Zhen Wang 1 , Yan-Jie Xu 1 , Chang-Ying Wang 3 , Hai-Ming Zhang 1, 2 , Rong-Xin Zhang 4 , Jian-Jun Zhang 1, 2 , Zhi Yao 3 , Zhong-Yang Shen 1, 2 1 First Central Clinical College, Tianjin Medical University, Tianjin, P.R. China 2 Oriental Organ Transplant Center of Tianjin First Central Hospital, Key Laboratory of Organ Transplantation of Tianjin, Tianjin, P.R.China 3 Department of Immunology, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Immuno Microenvironment and Disease of the Educational Ministry, Tianjin Medical University, Tianjin, P.R.China 4 Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Basic Medical College, Tianjin Medical University, Tianjin, P.R.China * These authors have contributed equally to this work Correspondence to: Jian-Jun Zhang, email: zhangjianjun9999@yeah.net Zhong-Yang Shen, email: zhongyangshen@vip.sina.com Rong-Xin Zhang, email: rongxinz@yahoo.com Zhi Yao, email: yaozhi@tijmu.edu.cn Keywords: hepatocellular carcinoma, lncRNA HULC, epithelial-mesenchymal transition, miR-200a-3p, ZEB1 Received: November 29, 2015 Accepted: May 14, 2016 Published: June 7, 2016 ABSTRACT Highly upregulated in liver cancer (HULC), a lncRNA that is considered a key molecule in human liver cancer, has recently been revealed to be involved in hepatocellular carcinoma (HCC) development and progression [1, 2]. It has been reported that HULC can promote tumor invasion and metastasis of HCC, but its function and mechanism of action in HCC have not been elucidated. In this study, we found that HULC was aberrantly up-regulated in HCC tissues and associated with TNM stage, intrahepatic metastases, HCC recurrence, and postoperative survival. HULC depletion inhibited the growth and metastasis of HCC cell lines in vitro and in vivo . Moreover, HULC contributes to ZEB1-induced epithelial-mesenchymal transition (EMT), a requirement for tumor invasion and metastasis that plays a key role in cancer progression. This effect of ZEB1 was inhibited by HULC siRNA. We conclude that the HULC functioned as a competing endogenous RNA (ceRNA) to mediate EMT via up-regulating ZEB1. In this way, it sequesters the miR-200a-3p signaling pathway to facilitate HCC metastasis. HULC comes into play as an oncogene in HCC, acting mechanistically by inducing HCC cells to activate EMT. Such an effect promotes tumor progression and metastasis through the miR-200a-3p/ZEB1 signaling pathway. The identification of this novel pathway that links high expression levels of HULC with EMT in HCC cells may serve as the foundation for the development of novel anti-tumor therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
CONG, N., DU, P., ZHANG, A., SHEN, F., SU, J., PU, P., WANG, T., ZJANG, J., KANG, C., & ZHANG, Q. (2013) · Oncology Reports · doi:10.3892/or.2013.2267 · Cited by 160
RetractedPeng, W., Gao, W., & Feng, J. (2014) · Medical Oncology · doi:10.1007/s12032-014-0346-4 · Cited by 144
RetractedLv, X., Li, L., Lv, L., Qu, X., Jin, S., Li, K., Deng, X., Cheng, L., He, H., & Dong, L. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0245-3 · Cited by 91
RetractedMiR-200 suppresses metastases of colorectal cancer through ZEB1
Sun, J., Ding, W., Zhi, J., & Chen, W. (2015) · Tumor Biology · doi:10.1007/s13277-015-3822-3 · Cited by 23
RetractedA ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Long non-coding RNAs: insights into functions
Mercer, T. R., Dinger, M. E., & Mattick, J. S. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2521 · Cited by 5,654
Zheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032
Fischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S., & Brabletz, T. (2008) · EMBO reports · doi:10.1038/embor.2008.74 · Cited by 1,722
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Wellner, U., Schubert, J., Burk, U. C., Schmalhofer, O., Zhu, F., Sonntag, A., Waldvogel, B., Vannier, C., Darling, D., Hausen, A. Z., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1998 · Cited by 1,699
Korpal, M., Lee, E. S., Hu, G., & Kang, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800074200 · Cited by 1,645
Bracken, C. P., Gregory, P. A., Kolesnikoff, N., Bert, A. G., Wang, J., Shannon, M. F., & Goodall, G. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1942 · Cited by 1,060
The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer?
Brabletz, S., & Brabletz, T. (2010) · EMBO reports · doi:10.1038/embor.2010.117 · Cited by 793
Panzitt, K., Tschernatsch, M. M. O., Guelly, C., Moustafa, T., Stradner, M., Strohmaier, H. M., Buck, C. R., Denk, H., Schroeder, R., Trauner, M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.08.026 · Cited by 771
E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer
Schmalhofer, O., Brabletz, S., & Brabletz, T. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9179-y · Cited by 765
Vincent, T., Neve, E. P. A., Johnson, J. R., Kukalev, A., Rojo, F., Albanell, J., Pietras, K., Virtanen, I., Philipson, L., Leopold, P. L., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1905 · Cited by 650
Liang, W.-C., Fu, W.-M., Wong, C.-W., Wang, Y., Wang, W.-M., Hu, G.-X., Zhang, L., Xiao, L.-J., Wan, D. C.-C., Zhang, J.-F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4154 · Cited by 571
Self-citationCui, M., Xiao, Z., Wang, Y., Zheng, M., Song, T., Cai, X., Sun, B., Ye, L., & Zhang, X. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1192 · Cited by 369
Du, Y., Kong, G., You, X., Zhang, S., Zhang, T., Gao, Y., Ye, L., & Zhang, X. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.342113 · Cited by 360
Xiong, H., Hong, J., Du, W., Lin, Y.-W., Ren, L.-L., Wang, Y.-C., Su, W.-Y., Wang, J.-L., Cui, Y., Wang, Z.-H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.295964 · Cited by 307
Self-citationPlasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma
Xie, H., Ma, H., & Zhou, D. (2013) · BioMed Research International · doi:10.1155/2013/136106 · Cited by 290
Yang, Y., Li, H., Hou, S., Hu, B., Liu, J., & Wang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065309 · Cited by 263
ZHAO, Y., GUO, Q., CHEN, J., HU, J., WANG, S., & SUN, Y. (2014) · Oncology Reports · doi:10.3892/or.2013.2850 · Cited by 260
Saydam, O., Shen, Y., Würdinger, T., Senol, O., Boke, E., James, M. F., Tannous, B. A., Stemmer-Rachamimov, A. O., Yi, M., Stephens, R. M., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00332-09 · Cited by 255
Long noncoding RNA-mediated anti-apoptotic activity in murine erythroid terminal differentiation
Hu, W., Yuan, B., Flygare, J., & Lodish, H. F. (2011) · Genes & Development · doi:10.1101/gad.178780.111 · Cited by 247
Hämmerle, M., Gutschner, T., Uckelmann, H., Ozgur, S., Fiskin, E., Gross, M., Skawran, B., Geffers, R., Longerich, T., Breuhahn, K., et al. (2013) · Hepatology · doi:10.1002/hep.26537 · Cited by 236
Stankic, M., Pavlovic, S., Chin, Y., Brogi, E., Padua, D., Norton, L., Massagué, J., & Benezra, R. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.014 · Cited by 221
Song, X., Cao, G., Jing, L., Lin, S., Wang, X., Zhang, J., Wang, M., Liu, W., & Lv, C. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12243 · Cited by 178
Self-citationZhou, J., Zeng, Q., Wang, H., Zhang, B., Li, S., Nan, X., Cao, N., Fu, C., Yan, X., Jia, Y., et al. (2015) · Hepatology · doi:10.1002/hep.27887 · Cited by 156
Self-citationA misplaced lncRNA causes brachydactyly in humans
Maass, P. G., Rump, A., Schulz, H., Stricker, S., Schulze, L., Platzer, K., Aydın, A., Tinschert, S., Goldring, M. B., Luft, F. C., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci65508 · Cited by 126
Zhang, F., Zhang, L., & Zhang, C. (2015) · Tumor Biology · doi:10.1007/s13277-015-4445-4 · Cited by 114
Wei, J., Zhang, Y., Luo, Y., Wang, Z., Bi, S., Song, D., Dai, Y., Wang, T., Qiu, L., Wen, L., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.10.811 · Cited by 100
Self-citationChu, P., Hu, F., Yu, C.-C., Tsai, L., Yu, C.-H., Wu, B.-C., Chen, Y., Huang, P., & Lo, W. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.07.012 · Cited by 99
Saito, T., Kurashige, J., Nambara, S., Komatsu, H., Hirata, H., Ueda, M., Sakimura, S., Uchi, R., Takano, Y., Shinden, Y., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4554-8 · Cited by 94
Yu, J., Sun, W., Hua, F., Xie, J., Lin, H., Zhou, D., & Hu, Z. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.05.029 · Cited by 93
LncRNA profiling reveals new mechanism for VDR protection against skin cancer formation
Jiang, Y. J., & Bikle, D. D. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.11.018 · Cited by 89
EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis through autophagy induction
Akalay, I., Janji, B., Hasmim, M., Noman, M. Z., Thiery, J. P., Mami‐Chouaib, F., & Chouaïb, S. (2013) · Autophagy · doi:10.4161/auto.24728 · Cited by 84
Long Non-Coding RNAs in Endometrial Carcinoma
Smolle, M. A., Bullock, M. D., Ling, H. Y., Pichler, M., & Haybaeck, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125962 · Cited by 72
Oyanagi, J., Ogawa, T., Sato, H., Higashi, S., & Miyazaki, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0053209 · Cited by 71
Epithelial Cell Differentiation Regulated by MicroRNA-200a in Mammary Glands
Nagaoka, K., Zhang, H., Watanabe, G., & Taya, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065127 · Cited by 48
Self-citationLong non-coding RNAs and hepatocellular carcinoma
Yu, F., Zheng, J., Dong, P., & Fan, X. (2014) · Molecular and Clinical Oncology · doi:10.3892/mco.2014.429 · Cited by 45
Long noncoding RNAs in T lymphocytes
Aune, T. M., Crooke, P. S., & Spurlock, C. F. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.1ri0815-389r · Cited by 37
Epithelial–mesenchymal transition and clinicopathological correlation in craniopharyngioma
Qi, S., Zhou, J., Pan, J., Zhang, C., Silky, C., & Yan, X.-R. (2012) · Histopathology · doi:10.1111/j.1365-2559.2012.04297.x · Cited by 33
Long noncoding RNAs in liver cancer: what we know in 2014
Zhao, J., Greene, C. M., Gray, S. G., & Lawless, M. W. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.941285 · Cited by 32
Bottoni, P., Isgrò, M. A., & Scatena, R. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2016.1112742 · Cited by 18
Cited by
Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications
Wong, C.-M., Tsang, F. H.-C., & Ng, I. O.-L. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.169 · Cited by 424
Xiong, H., Ni, Z., He, J., Jiang, S., Li, X., He, J., Gong, W., Zheng, L., Chen, S., Li, B., et al. (2017) · Oncogene · doi:10.1038/onc.2016.521 · Cited by 362
Self-citationNon-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets
Klingenberg, M., Matsuda, A., Diederichs, S., & Patel, T. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.04.009 · Cited by 354
The multiverse nature of epithelial to mesenchymal transition
Simeone, P., Trerotola, M., Franck, J., Cardon, T., Marchisio, M., Fournier, I., Salzet, M., Maffia, M., & Vergara, D. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.11.004 · Cited by 98
Rusu, I., Pirlog, R., Chiroi, P., Nutu, A., Puia, V. R., Fetti, A. C., Rusu, D. R., Berindan-Neagoe, I., & Al Hajjar, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012370 · Cited by 27
Metadata
- Authors
- Li, S.-P., Xu, H.-X., Yu, Y., He, J.-D., Wang, Z., Xu, Y.-J., Wang, C.-Y., Zhang, H.-M., Zhang, R.-X., Zhang, J.-J., Yao, Z., & Shen, Z.-Y.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-06-07
- Volume
- 7
- Issue
- 27
- Pages
- 42431-42446
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2417073627
- Cited by
- 268
- References
- 45
- FWCI
- 17.59
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.